944 related articles for article (PubMed ID: 16775378)
1. Pathomechanisms of mutant proteins in Charcot-Marie-Tooth disease.
Niemann A; Berger P; Suter U
Neuromolecular Med; 2006; 8(1-2):217-42. PubMed ID: 16775378
[TBL] [Abstract][Full Text] [Related]
2. Schwann cells and the pathogenesis of inherited motor and sensory neuropathies (Charcot-Marie-Tooth disease).
Berger P; Niemann A; Suter U
Glia; 2006 Sep; 54(4):243-57. PubMed ID: 16856148
[TBL] [Abstract][Full Text] [Related]
3. Charcot-Marie-Tooth disease: an update.
Shy ME
Curr Opin Neurol; 2004 Oct; 17(5):579-85. PubMed ID: 15367862
[TBL] [Abstract][Full Text] [Related]
4. Molecular genetics of autosomal-dominant demyelinating Charcot-Marie-Tooth disease.
Houlden H; Reilly MM
Neuromolecular Med; 2006; 8(1-2):43-62. PubMed ID: 16775366
[TBL] [Abstract][Full Text] [Related]
5. Molecular genetics of autosomal-dominant axonal Charcot-Marie-Tooth disease.
Züchner S; Vance JM
Neuromolecular Med; 2006; 8(1-2):63-74. PubMed ID: 16775367
[TBL] [Abstract][Full Text] [Related]
6. [Molecular genetics of inherited neuropathies].
Takashima H
Rinsho Shinkeigaku; 2006 Jan; 46(1):1-18. PubMed ID: 16541790
[TBL] [Abstract][Full Text] [Related]
7. Genetic epidemiology of Charcot-Marie-Tooth disease.
Braathen GJ
Acta Neurol Scand Suppl; 2012; (193):iv-22. PubMed ID: 23106488
[TBL] [Abstract][Full Text] [Related]
8. Analyzing histopathological features of rare charcot-marie-tooth neuropathies to unravel their pathogenesis.
Benedetti S; Previtali SC; Coviello S; Scarlato M; Cerri F; Di Pierri E; Piantoni L; Spiga I; Fazio R; Riva N; Natali Sora MG; Dacci P; Malaguti MC; Munerati E; Grimaldi LM; Marrosu MG; De Pellegrin M; Ferrari M; Comi G; Quattrini A; Bolino A
Arch Neurol; 2010 Dec; 67(12):1498-505. PubMed ID: 21149811
[TBL] [Abstract][Full Text] [Related]
9. Demyelinating and axonal features of Charcot-Marie-Tooth disease with mutations of myelin-related proteins (PMP22, MPZ and Cx32): a clinicopathological study of 205 Japanese patients.
Hattori N; Yamamoto M; Yoshihara T; Koike H; Nakagawa M; Yoshikawa H; Ohnishi A; Hayasaka K; Onodera O; Baba M; Yasuda H; Saito T; Nakashima K; Kira J; Kaji R; Oka N; Sobue G;
Brain; 2003 Jan; 126(Pt 1):134-51. PubMed ID: 12477701
[TBL] [Abstract][Full Text] [Related]
10. Targeting the colony stimulating factor 1 receptor alleviates two forms of Charcot-Marie-Tooth disease in mice.
Klein D; Patzkó Á; Schreiber D; van Hauwermeiren A; Baier M; Groh J; West BL; Martini R
Brain; 2015 Nov; 138(Pt 11):3193-205. PubMed ID: 26297559
[TBL] [Abstract][Full Text] [Related]
11. Charcot-Marie-Tooth disease and related neuropathies: mutation distribution and genotype-phenotype correlation.
Boerkoel CF; Takashima H; Garcia CA; Olney RK; Johnson J; Berry K; Russo P; Kennedy S; Teebi AS; Scavina M; Williams LL; Mancias P; Butler IJ; Krajewski K; Shy M; Lupski JR
Ann Neurol; 2002 Feb; 51(2):190-201. PubMed ID: 11835375
[TBL] [Abstract][Full Text] [Related]
12. Myotubularin-related 2 protein phosphatase and neurofilament light chain protein, both mutated in CMT neuropathies, interact in peripheral nerve.
Previtali SC; Zerega B; Sherman DL; Brophy PJ; Dina G; King RH; Salih MM; Feltri L; Quattrini A; Ravazzolo R; Wrabetz L; Monaco AP; Bolino A
Hum Mol Genet; 2003 Jul; 12(14):1713-23. PubMed ID: 12837694
[TBL] [Abstract][Full Text] [Related]
13. Role of immune cells in animal models for inherited peripheral neuropathies.
Wang Ip C; Kroner A; Fischer S; Berghoff M; Kobsar I; Mäurer M; Martini R
Neuromolecular Med; 2006; 8(1-2):175-90. PubMed ID: 16775375
[TBL] [Abstract][Full Text] [Related]
14. Charcot-Marie-Tooth disease and related peripheral neuropathies: novel mutations in the peripheral myelin genes connexin 32 (Cx32), peripheral myelin protein 22 (PMP22), and peripheral myelin protein zero (MPZ).
Ekici AB; Schweitzer D; Park O; Lorek D; Rautenstrauss B; Krüger G; Friedl W; Uhlhaas S; Bathke K; Heuss D; Kayser C; Grehl H
Neurogenetics; 2000 Sep; 3(1):49-50. PubMed ID: 11085599
[No Abstract] [Full Text] [Related]
15. Genetic profile and onset features of 1005 patients with Charcot-Marie-Tooth disease in Japan.
Yoshimura A; Yuan JH; Hashiguchi A; Ando M; Higuchi Y; Nakamura T; Okamoto Y; Nakagawa M; Takashima H
J Neurol Neurosurg Psychiatry; 2019 Feb; 90(2):195-202. PubMed ID: 30257968
[TBL] [Abstract][Full Text] [Related]
16. [Molecular mechanisms of hereditary neuropathy: genotype-phenotype correlation].
Nakagawa M; Takashima H
Rinsho Byori; 2003 Jun; 51(6):536-43. PubMed ID: 12884740
[TBL] [Abstract][Full Text] [Related]
17. Different consequences of EGR2 mutants on the transactivation of human Cx32 promoter.
Musso M; Balestra P; Taroni F; Bellone E; Mandich P
Neurobiol Dis; 2003 Feb; 12(1):89-95. PubMed ID: 12609493
[TBL] [Abstract][Full Text] [Related]
18. [Genetic diagnosis and molecular pathology of inherited neuropathy].
Takashima H
Rinsho Shinkeigaku; 2012; 52(6):399-404. PubMed ID: 22790800
[TBL] [Abstract][Full Text] [Related]
19. Phenotypic differences between peripheral myelin protein-22 (PMP22) and myelin protein zero (P0) mutations associated with Charcot-Marie-Tooth-related diseases.
Shames I; Fraser A; Colby J; Orfali W; Snipes GJ
J Neuropathol Exp Neurol; 2003 Jul; 62(7):751-64. PubMed ID: 12901701
[TBL] [Abstract][Full Text] [Related]
20. SOX10 regulates an alternative promoter at the Charcot-Marie-Tooth disease locus MTMR2.
Fogarty EA; Brewer MH; Rodriguez-Molina JF; Law WD; Ma KH; Steinberg NM; Svaren J; Antonellis A
Hum Mol Genet; 2016 Sep; 25(18):3925-3936. PubMed ID: 27466180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
